Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Wurden

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Epilepsy Research|November 30, 2002
Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19F Lakehal, C J Wurden, T F Kalhorn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1996
Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19L C Wienkers, C J Wurden, E Storch, et al.
Biochemical Pharmacology|June 1, 1994
Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formationB M Kerr, K E Thummel, C J Wurden, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constantsA Tran, E Rey, G Pons, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Epilepsy Research|November 30, 2002
Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19F Lakehal, C J Wurden, T F Kalhorn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1996
Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19L C Wienkers, C J Wurden, E Storch, et al.
Biochemical Pharmacology|June 1, 1994
Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formationB M Kerr, K E Thummel, C J Wurden, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constantsA Tran, E Rey, G Pons, et al.
Pageof 1